Table 1

 Patient groups, growth factor, and protein levels

Sample typeTGF-β2 (ng/ml)B-FGF (pg/ml)Il-6 (pg/ml)Protein (mg/ml)
Median (IQR)Median (IQR)Median (IQR)Median (IQR)
IQR, interquartile range.
Retro-oil fluid (n = 13)1.65 (1.03–2.30)50.85 (28.46–60.48)572.18 (523.81–581.37)736.32 (343.63–1368.56)
Macular hole vitreous (n = 10)1.07 (0.65–1.90)0.18 (0.15–1.76)0.98 (0.9–1.43)20.60 (8.95–49.83)
Revision-vitrectomy fluid (n = 11)1.24 (0.93–1.78)2.14 (1.05–2.48)515.18 (78.38–615.08)149.22 (46.77–593.8)
No preoperative PVR vitreous (n = 244)1.54 (0.70–3.13)1.99 (0.72–10.77)106.88 (31.28–384.23)75.5 (30–151)
Preoperative PVR vitreous (n = 31)1.70 (1.03–2.85)13.21 (5.11–59.19)296.93 (63.0–628.58)218 (112–706.92)
Non retro-oil samples combined1.51 (0.79–3.1)2.23 (0.77–12.63)110.1 (29.18–418.65)81.5 (30.415–173.98)